a:1:{s:5:"en_US";s:2:"MD";}.
Resident in Internal Medicine.
Acta Biomed. 2022 Mar 14;93(1):e2022030. doi: 10.23750/abm.v93i1.10982.
With the rising number of COVID-19 patients, there have been reports of patients presenting with concomitant infective endocarditis. In this retrospective review, we included all articles from Medline with COVID-19 and infective endocarditis coinfection. Ten articles were identified from eight different countries over the world over the past 11 months. All patients reported with the above coinfections were male with a mean age of 53 years. Clinical features of COVID-19 and the presence of ground-glass opacity in CT thorax were predominant among patients with positive RT-PCR for COVID-19. New-onset embolic infarct, pulmonary edema was a contributor to the diagnosis of endocarditis in most patients. Involvement of the aortic valve was most common. Delayed diagnosis and cardiac surgery were contributors to increased morbidity.
随着 COVID-19 患者数量的增加,有报道称患者同时患有感染性心内膜炎。在这项回顾性研究中,我们纳入了 Medline 上所有关于 COVID-19 和感染性心内膜炎合并感染的文章。在过去的 11 个月中,从世界上八个不同的国家共确定了 10 篇文章。所有报告的合并感染患者均为男性,平均年龄为 53 岁。COVID-19 的临床特征和 CT 胸部磨玻璃影的存在在 COVID-19 阳性 RT-PCR 患者中较为常见。大多数患者的新发栓塞性梗死和肺水肿有助于心内膜炎的诊断。主动脉瓣受累最为常见。诊断延迟和心脏手术是导致发病率增加的原因。